Ceribelli, Angela
 Distribuzione geografica
Continente #
NA - Nord America 2.342
EU - Europa 895
AS - Asia 745
AF - Africa 654
SA - Sud America 226
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.865
Nazione #
US - Stati Uniti d'America 2.327
SC - Seychelles 610
SG - Singapore 371
CN - Cina 268
BR - Brasile 202
FI - Finlandia 202
IT - Italia 194
IE - Irlanda 140
DE - Germania 81
FR - Francia 63
NL - Olanda 49
IN - India 39
GB - Regno Unito 34
NG - Nigeria 28
RU - Federazione Russa 21
SE - Svezia 20
MK - Macedonia 19
CZ - Repubblica Ceca 14
AR - Argentina 11
BE - Belgio 10
TR - Turchia 10
PH - Filippine 8
JP - Giappone 7
EC - Ecuador 6
IL - Israele 6
MX - Messico 6
CH - Svizzera 5
IQ - Iraq 5
PK - Pakistan 5
PL - Polonia 5
CA - Canada 4
HK - Hong Kong 4
JO - Giordania 4
MA - Marocco 4
NO - Norvegia 4
UA - Ucraina 4
AT - Austria 3
BG - Bulgaria 3
DK - Danimarca 3
ES - Italia 3
PT - Portogallo 3
RO - Romania 3
TN - Tunisia 3
UZ - Uzbekistan 3
VE - Venezuela 3
AL - Albania 2
BD - Bangladesh 2
CL - Cile 2
DZ - Algeria 2
EE - Estonia 2
EG - Egitto 2
HU - Ungheria 2
VN - Vietnam 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AO - Angola 1
AU - Australia 1
BS - Bahamas 1
BW - Botswana 1
CO - Colombia 1
DO - Repubblica Dominicana 1
EU - Europa 1
HN - Honduras 1
HR - Croazia 1
IS - Islanda 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LI - Liechtenstein 1
LV - Lettonia 1
MM - Myanmar 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TH - Thailandia 1
UG - Uganda 1
ZA - Sudafrica 1
Totale 4.865
Città #
Chandler 606
Shanghai 227
Helsinki 202
Boardman 163
The Dalles 152
Dublin 140
Wilmington 133
Ashburn 131
Singapore 127
New York 121
Paris 56
San Mateo 54
Los Angeles 51
Milan 49
Amsterdam 35
Ann Arbor 34
Benin City 27
Pune 27
Lawrence 26
Princeton 26
Leawood 23
London 21
Naples 21
Council Bluffs 17
Phoenix 16
Woodbridge 16
Fairfield 13
Seattle 13
São Paulo 12
Brno 11
Brussels 10
Santa Clara 10
Falkenstein 9
Skopje 9
Munich 8
Rio de Janeiro 8
Sassari 8
Belo Horizonte 7
Hyderabad 7
Aurora 6
Frankfurt am Main 6
Rome 6
San Diego 6
Stockholm 6
Bitola 5
Kocaeli 5
Abbiategrasso 4
Amman 4
Buenos Aires 4
Hong Kong 4
Moscow 4
Oslo 4
Redwood City 4
Tel Aviv 4
Trieste 4
Turin 4
Usmate Velate 4
Americana 3
Caxias do Sul 3
Curitiba 3
Düsseldorf 3
Falls Church 3
Guayaquil 3
Istanbul 3
Limeira 3
Olongapo City 3
Praia Grande 3
Prilep 3
Tashkent 3
Tokyo 3
Toronto 3
Warsaw 3
Zurich 3
Acerra 2
Andover 2
Arzano 2
Baghdad 2
Bari 2
Betim 2
Bogovinje 2
Bologna 2
Brasília 2
Brescia 2
Budapest 2
Cairo 2
Campinas 2
Campo Grande 2
Catania 2
Chennai 2
Chieve 2
Conselheiro Lafaiete 2
Dhaka 2
Franca 2
Gdansk 2
Guangzhou 2
Hangzhou 2
Hanover 2
Houston 2
Islamabad 2
Jundiaí 2
Totale 2.812
Nome #
Serum anti-phospholipid antibody prevalence and cardiovascular significance in the general population of the camelia study 648
Outcome of Sars-COV-2-related thyrotoxicosis in survivors of Covid-19: a prospective study 156
Personalized medicine in rheumatology : the paradigm of serum autoantibodies 94
UTILIZZO DELLA MEPACRINA COME TERAPIA DELLE MANIFESTAZIONI CUTANEE NELLE CONNETTIVITI 88
Safety issues and concerns of new immunomodulators in rheumatology 79
Acute phase reactions after zoledronic acid infusion: protective role of 25-OH vitamin D and previous oral bisphosphonate therapy 74
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 73
Gamma-delta T lymphocytes and 25-hydroxy vitamin D levels as key factors in autoimmunity and inflammation : the case of zoledronic acid-induced acute phase reaction 69
Anti-phospholipid antibody prevalence and association with subclinical atherosclerosis and atherothrombosis in the general population 67
Serum antinuclear and extractable nuclear antigen antibody prevalence and associated morbidity and mortality in the general population over 15 years 62
Anti-RNA polymerase III antibodies: a marker of systemic sclerosis with rapid onset and skin thickening progression 59
Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis 59
Lessons learned from twins in autoimmune and chronic inflammatory diseases 55
The Immune Response and the Pathogenesis of Idiopathic Inflammatory Myositis : a Critical Review 53
A case of psoriatic arthritis triggered by SARS-CoV-2 infection 52
Suspected and unsuspected factors in the multifaceted immunopathology of viral hepatitis 52
Prevalence and clinical significance of anti-MDA5 antibodies in European patients with polymyositis/dermatomyositis 52
Nailfold videocapillaroscopy and serum VEGF levels in scleroderma are associated with internal organ involvement 49
DNA Methylation Signature in Monozygotic Twins Discordant for Psoriatic Disease 48
PFAPA syndrome and Behçet’s disease : a comparison of two medical entities based on the clinical interviews performed by three different specialists 48
Effects of type II collagen epitope carbamylation and citrullination in HLA-DR4+ monozygotic twins discordant for rheumatoid arthritis 47
Disease knowledge index and perspectives on reproductive issues: A nationwide study on 398 women with autoimmune rheumatic diseases 46
Anti-MDA5 Antibody Linking COVID-19, Type I Interferon, and Autoimmunity: A Case Report and Systematic Literature Review 45
Additional organs involved in antiphospholipid syndrome : eye, ear-nose-throat, lung, gastroenteric system, endocrine glands 45
A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy 45
AUTOANTIBODY TO RNA-PROTEIN COMPLEX DETECTED BY QUANTITATIVE PCR 44
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases 44
Anti-Th/To are common antinucleolar autoantibodies in Italian patients with scleroderma 44
Anti-TNF-alpha treatment in rheumatoid arthritis with anti-Ro/SSA antibodies. Analysis of 17 cases among a cohort of 322 treated patients 44
Humoral Response Against LL-37 in Psoriatic Disease: Comment on the Article by Yuan et al 43
Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis 43
Detection of anti-mitochondrial antibodies by immunoprecipitation in patients with systemic sclerosis 43
Autoantibodies as biomarkers for interstitial lung disease in idiopathic inflammatory myositis and systemic sclerosis: The case of anti-eIF2B antibodies 42
Anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus patients with articular involvement: a predictive marker for erosive disease? 42
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course. 42
Anti-RNA polymerase III antibodies as a risk marker for early gastric antral vascular ectasia (GAVE) in systemic sclerosis 41
Comment on: Inflammatory myopathy associated with anti-mitochondrial antibodies: A distinct phenotype with cardiac involvement 41
[TNF-alpha inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunologic effects] 40
Short-Term Adverse Events and Antibody Response to the BNT162b2 SARS-CoV-2 Vaccine in 4156 Health Care Professionals 39
Long-term Outcome of Children Born to Women with Autoimmune Rheumatic Diseases: A Multicentre, Nationwide Study on 299 Randomly Selected Individuals 38
MicroRNAs in rheumatoid arthritis 38
Elastic properties of the ascending aorta in patients with rheumatoid arthritis 38
Seronegative reactive spondyloarthritis and the skin 38
Anti-argonaute2 (Ago2/Su) and -Ro antibodies identified by immunoprecipitation in primary anti-phospholipid syndrome (PAPS) 37
Antigen Reactivity and Clinical Significance of Autoantibodies Directed Against the Pyruvate Dehydrogenase Antigen Complex in Patients With Connective Tissue Disease 37
Clinical Significance of Antinucleolar Antibodies: Biomarkers for Autoimmune Diseases, Malignancies, and others 36
Isotype switching and titer variation of anti-Ro/SSA antibodies over time in 100 patients with undifferentiated connective tissue disease (UCTD) 35
The Th17 axis in psoriatic disease : pathogenetic and therapeutic implications 35
ANTI-RNA POLYMERASE III ANTIBODIES AS A RISK MARKER FOR EARLY DEVELOPMENT OF GASTRIC ANTRAL VASCULAR ECTASIA IN SYSTEMIC SCLEROSIS 34
Environmental triggers for connective tissue disease: the case of COVID-19 associated with dermatomyositis-specific autoantibodies 34
Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers 33
Neuropsychiatric aid in children born to patients with rheumatic diseases 33
Reference standards for the detection of anti-mitochondrial and anti-rods/rings autoantibodies 33
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life Setting 32
Complement cascade in systemic lupus erythematosus: analyses of the three activation pathways 32
Malignancies in Italian patients with systemic sclerosis positive for anti-RNA polymerase III antibodies 32
MicroRNAs and autoimmunity 31
Gender and ethnicity differences in the prevalence of scleroderma-related autoantibodies 30
A new immunoprecipitation-real time quantitative PCR assay for anti-Th/To and anti-U3RNP antibody detection in systemic sclerosis 30
The interplay of epigenetics and epidemiology in autoimmune diseases: time for geoepigenetics 30
The geoepidemiology of autoimmune liver disease 30
Clinical Trials Supporting the Role of the IL-17/IL-23 Axis in Axial Spondyloarthritis 30
Calcinosis in poly-dermatomyositis: clinical and laboratory predictors and treatment options 29
An Italian Multicenter Study on Anti-NXP2 Antibodies: Clinical and Serological Associations 29
Cardiological features in idiopathic inflammatory myopathies 28
Autoantibodies to transcription intermediary factor TIF1β associated with dermatomyositis 28
Evaluation of a novel particle-based assay for detection of autoantibodies in idiopathic inflammatory myopathies 28
MicroRNA-146a in autoimmunity and innate immune responses 27
Atypical clinical presentation of a subset of patients with anti-RNA polymerase III--non-scleroderma cases associated with dominant RNA polymerase I reactivity and nucleolar staining 27
Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy 27
Medical cannabis and cannabinoids in rheumatology: where are we now? 26
Psoriatic arthritis induced by anti-PD1 and treated with apremilast: a case report and review of the literature 26
Autoantibodies to survival of motor neuron complex in patients with polymyositis: immunoprecipitation of D, E, F, and G proteins without other components of small nuclear ribonucleoproteins 26
Differential reactivity to IMPDH2 by anti-rods/rings autoantibodies and unresponsiveness to pegylated interferon-alpha/ribavirin therapy in US and Italian HCV patients 26
Impact of chronic exposure to 5-alpha reductase inhibitors on the risk of hospitalization for COVID-19: a case-control study in male population from two COVID-19 regional centers of Lombardy, Italy 26
Evaluation of mortality, disease activity, treatment, clinical and immunological features of adult and late onset systemic Lupus erythematosus 25
Lupus T cells switched on by DNA hypomethylation via microRNA? 25
Elevated signal transducers and activators of transcription 1 correlates with increased C-C motif chemokine ligand 2 and C-X-C motif chemokine 10 levels in peripheral blood of patients with systemic lupus erythematosus 25
LUPUS ERITEMATOSO SISTEMICO AD ESORDIO TARDIVO: CARATTERISTICHE CLINICHE ED IMMUNOLOGICHE 25
ANTICORPI ANTI-CCP: LIMITI E SVANTAGGI 25
Frequent coexistence of anti-topoisomerase I and anti-U1RNP autoantibodies in African American patients associated with mild skin involvement: a retrospective clinical study 24
Treatment with etanercept in six patients with chronic hepatitis C infection and systemic autoimmune diseases 24
Aortic stiffness and left ventricular hypertrophy in rheumatoid arthritis: comment on the article by Rudominer et al 24
Treatment of lupus skin involvement with quinacrine and hydroxychloroquine 22
Lymphocyte modulation by tofacitinib in patients with rheumatoid arthritis 21
ANTICORPI ANTI-TH/TO NELLA SCLEROSI SISTEMICA (SSC): CORRELAZIONI CLINICHE E IMMUNOLOGICHE 21
ANTICORPI ANTI-PEPTIDE CITRULLINATO CICLICO (ANTI-CCP): QUALE UTILITA' NELLA DIAGNOSI DIFFERENZIALE TRA ARTRITE REUMATOIDE E CONNETTIVITI? 21
ANTICORPI ANTI-RNA POLIMERASI III: UN MARKER DI ESORDIO PRECOCE DI SCLEROSI SISTEMICA 20
Sex and autoimmune disease: Four mechanisms pointing at women 20
International cohort study of 73 anti-Ku-positive patients: association of p70/p80 anti-Ku antibodies with joint/bone features and differentiation of disease populations by using principal-components analysis 20
Unmet needs and perspectives in rheumatoid arthritis-associated interstitial lung disease: A critical review 20
Racial differences in systemic sclerosis disease presentation: a European Scleroderma Trials and Research group study 20
Coexistence of anti-RNA polymerase III and anti-U1RNP antibodies in patients with systemic lupus erythematosus: two cases without features of scleroderma 19
Hepatitis C virus infection and primary Sjögren's syndrome: a clinical and serologic description of 9 patients 19
mRNA COVID-19 vaccine booster fosters B- and T-cell responses in immunocompromised patients 19
Unusual association between pure red cell aplasia and primary Sjögren's syndrome: a case report 19
ANTICORPI ANTI-SU NELLA SINDROME DA ANTICORPI ANTI-FOSFOLIPIDI PRIMARIA (PAPS) 18
Left ventricular Systolic and diastolic function in rheumatoid arthritis 18
Left ventricular sistolic and diastolic function in rheumatoid arthritis 18
Rpp25 is a major target of autoantibodies to the Th/To complex as measured by a novel chemiluminescent assay 18
Totale 4.416
Categoria #
all - tutte 36.361
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.361


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021272 9 4 9 0 1 71 32 16 61 26 2 41
2021/2022147 8 2 2 33 2 1 4 18 12 16 29 20
2022/20231.483 77 103 122 191 129 142 5 180 254 132 128 20
2023/20241.167 127 77 257 92 48 181 77 32 20 60 64 132
2024/20251.870 38 37 636 57 83 227 144 131 293 224 0 0
Totale 4.939